MediTip Co., Ltd.

Based in Seoul, South Korea, and founded in 2006, MediTip Co. , Ltd. offers regulatory consulting and assistance to assist bio and medical device companies in the approval processes and effectively launch their products in global markets. In November 2024, MediTip Co.

, Ltd. raised KRW 4 billion in venture funding from HighLight Capital. As of 2024, the company is led by its CEO, Yoo Jung-hee. MediTip Co.

, Ltd. provides consulting services for healthcare regulatory approvals, primarily in the biopharmaceutical and medical device sectors. The company offers regulatory affairs (RA) and quality assurance (QA) services, helping clients navigate approval processes for pharmaceuticals, biologics, cell therapies, and medical devices. MediTip works with global regulatory bodies to support product approvals in markets such as the United States, Europe, Japan, and China, serving biopharmaceutical companies and medical device manufacturers.

The company generates revenue through service contracts and consulting fees related to healthcare product regulatory approvals. Their transactional structure is B2B, offering tailored consulting services that ensure compliance with local regulations and international standards. The firm engages in service agreements that may involve project-based fees or retainer arrangements, providing ongoing support during the product development lifecycle. Their services are essential for clients aiming to secure approvals from regulatory agencies such as the FDA, EMA, NMPA, and PMDA, facilitating efficient market entry.

The company aims to enhance its service offerings and expand into new markets, with a focus on increasing its presence in regions such as Southeast Asia and South America by 2025.